Armlogi Holding Corp. Announces Revenue Growth Of 16.5% To $49.5 Million
| ARMLOGI HOLDING CORP. CONSOLIDATED BALANCE SHEETS AS OF SEPTEMBER 30, 2025 AND JUNE 30, 2025 (US$, except share data, or otherwise noted) | |||||||
| September 30, 2025 | June 30, 2025 | ||||||
| US$ | US$ | ||||||
| Unaudited | Audited | ||||||
| Assets | |||||||
| Current assets | |||||||
| Cash | 6,456,745 | 9,190,277 | |||||
| Accounts receivable and other receivable, net of credit loss allowance of $594,869 and $594,869 | 18,390,255 | 22,207,500 | |||||
| Other current assets | 985,422 | 998,925 | |||||
| Prepaid expenses | 1,667,446 | 1,375,646 | |||||
| Loan receivables | 1,713,324 | 3,893,563 | |||||
| Total current assets | 29,213,192 | 37,665,911 | |||||
| Non-current assets | |||||||
| Restricted cash – non-current | 4,391,165 | 4,387,550 | |||||
| Long-term loan receivables | 822,305 | - | |||||
| Property and equipment, net | 10,646,576 | 11,259,820 | |||||
| Intangible assets, net | 43,032 | 54,627 | |||||
| Right-of-use assets – operating leases | 109,518,130 | 115,361,185 | |||||
| Right-of-use assets – finance leases | 831,474 | 745,547 | |||||
| Other non-current assets | 871,691 | 739,555 | |||||
| Total assets | 156,337,565 | 170,214,195 | |||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||
| Liabilities: | |||||||
| Current liabilities | |||||||
| Accounts payable and accrued liabilities | 8,042,768 | 9,604,783 | |||||
| Contract liabilities | 826,814 | 939,097 | |||||
| Accrued payroll liabilities | 614,553 | 283,150 | |||||
| Convertible notes | - | 5,292,749 | |||||
| Operating lease liabilities – current | 30,348,333 | 29,280,907 | |||||
| Finance lease liabilities – current | 447,338 | 386,327 | |||||
| Total current liabilities | 40,279,806 | 45,787,013 | |||||
| Non-current liabilities | |||||||
| Operating lease liabilities – non-current | 93,254,743 | 98,939,552 | |||||
| Finance lease liabilities – non-current | 421,131 | 397,692 | |||||
| Total liabilities | 133,955,680 | 145,124,257 | |||||
| Stockholders' equity | |||||||
| Common stock, US$0.00001 par value, 100,000,000 shares authorized, 45,443,079 and 42,250,934 issued and outstanding as of September 30, 2025 and June 30, 2025, respectively | 454 | 422 | |||||
| Additional paid-in capital | 20,468,826 | 16,668,858 | |||||
| Retained earnings | 1,912,605 | 8,420,658 | |||||
| Total stockholders' equity | 22,381,885 | 25,089,938 | |||||
| Total liabilities and stockholders' equity | 156,337,565 | 170,214,195 | |||||
| ARMLOGI HOLDING CORP. CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2025 AND 2024 (US$, except share data, or otherwise noted) | |||||||
| For The Three Months Ended September 30, 2025 | For The Three Months Ended September 30, 2024 | ||||||
| US$ | US$ | ||||||
| Unaudited | Unaudited | ||||||
| Revenue | 49,473,179 | 42,481,896 | |||||
| Costs of services | 51,957,262 | 46,088,686 | |||||
| Gross loss | (2,484,083 | ) | (3,606,790 | ) | |||
| Operating costs and expenses: | |||||||
| General and administrative | 4,217,306 | 3,668,825 | |||||
| Total operating costs and expenses | 4,217,306 | 3,668,825 | |||||
| Loss from operations | (6,701,389 | ) | (7,275,615 | ) | |||
| Other (income) expenses: | |||||||
| Other income, net | (738,592 | ) | (1,205,665 | ) | |||
| Finance costs | 548,345 | 9,008 | |||||
| Total other (income) expenses | (190,247 | ) | (1,196,657 | ) | |||
| Loss before provision for income taxes | (6,511,142 | ) | (6,078,958 | ) | |||
| Current income tax recovery | (3,089 | ) | (57,589 | ) | |||
| Deferred income tax recovery | - | (1,373,498 | ) | ||||
| Total income tax recovery | (3,089 | ) | (1,431,087 | ) | |||
| Net loss | (6,508,053 | ) | (4,647,871 | ) | |||
| Total comprehensive loss | (6,508,053 | ) | (4,647,871 | ) | |||
| Basic & diluted net loss per share | (0.15 | ) | (0.11 | ) | |||
| Weighted average number of shares of common stock-basic and diluted | 42,462,207 | 41,634,000 | |||||
| ARMLOGI HOLDING CORP. CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2025 AND 2024 (UNAUDITED) (US$, except share data, or otherwise noted) | |||||||
| For The Three Months Ended September 30, 2025 | For The Three Months Ended September 30, 2024 | ||||||
| US$ | US$ | ||||||
| Unaudited | Unaudited | ||||||
| Cash Flows from Operating Activities: | |||||||
| Net loss | (6,508,053 | ) | (4,647,871 | ) | |||
| Adjustments for items not affecting cash: | |||||||
| Depreciation of property and equipment and right-of-use financial assets | 778,520 | 617,166 | |||||
| Amortization | 11,595 | 8,829 | |||||
| Non-cash operating leases expense | 1,225,671 | 2,682,178 | |||||
| Current estimated credit loss | - | 126,936 | |||||
| Accretion of convertible notes | 527,251 | - | |||||
| Deferred income taxes | - | (1,373,498 | ) | ||||
| Interest income | (15,375 | ) | (33,736 | ) | |||
| Changes in operating assets and liabilities | |||||||
| Accounts receivable and other receivables | 3,817,245 | 160,623 | |||||
| Other current assets | 13,503 | (250,770 | ) | ||||
| Other non-current assets | (132,136 | ) | (106,085 | ) | |||
| Prepaid expenses | (291,799 | ) | 316,745 | ||||
| Accounts payable & accrued liabilities | (1,574,944 | ) | (1,927,718 | ) | |||
| Contract liabilities | 112,283 | 498,249 | |||||
| Income tax payable | - | (57,589 | ) | ||||
| Accrued payroll liabilities | 331,403 | 374,429 | |||||
| Net cash used in operating activities | (1,929,402 | ) | (3,612,112 | ) | |||
| Cash Flows from Investing Activities: | |||||||
| Purchase of property and equipment | (56,077 | ) | (1,353,297 | ) | |||
| Loan disbursement | (2,370,000 | ) | (1,000,000 | ) | |||
| Proceeds from loan repayments | 3,743,309 | 1,036,705 | |||||
| Net cash provided by (used in) investing activities | 1,317,232 | (1,316,592 | ) | ||||
| Cash Flows from Financing Activities: | |||||||
| Repayments of finance lease liabilities | (97,747 | ) | (35,831 | ) | |||
| Repayments of convertible notes | (2,020,000 | ) | - | ||||
| Net cash used in financing activities | (2,117,747 | ) | (35,831 | ) | |||
| Net decrease in cash and cash equivalents and restricted cash | (2,729,917 | ) | (4,964,535 | ) | |||
| Cash and cash equivalents and restricted cash, beginning of the period | 13,577,827 | 9,950,384 | |||||
| Cash and cash equivalents and restricted cash, end of the period | 10,847,910 | 4,985,849 | |||||
The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the Consolidated Balance Sheets that total the same amounts shown in the Consolidated Statements of Cash Flows:
| Cash and cash equivalents | 6,456,745 | 2,924,176 | |||||
| Restricted cash – non-current | 4,391,165 | 2,061,673 | |||||
| Total cash and cash equivalents and restricted cash shown in the Consolidated Balance Sheet | 10,847,910 | 4,985,849 | |||||
| Supplemental Disclosure of Cash Flows Information: | |||||||
| Non-cash Transactions: | |||||||
| Right-of-use assets acquired in exchange for finance lease liabilities | 182,197 | - | |||||
| Shares issued for Investor Notices pursuant to Standby Equity Purchase Agreement | 3,800,000 | - | |||||

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment